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Epilepsy is characterized by spontaneous recurrent seizures and comprises a diverse group
of syndromes with different etiologies. Epileptogenesis refers to the process whereby the
brain becomes epileptic and can be related to several factors, such as acquired structural
brain lesions, inborn brain malformations, alterations in neuronal signaling, and defects in
maturation and plasticity of neuronal networks. In this review, we will focus on alterations
of brain development that lead to an hyperexcitability phenotype in adulthood, providing
examples from both animal and human studies. Malformations of cortical development
(including focal cortical dysplasia, lissencephaly, heterotopia, and polymicrogyria) are fre-
quently epileptogenic and result fromdefects in cell proliferation in the germinal zone and/or
impaired neuronal migration and differentiation. Delayed or reduced arrival of inhibitory
interneurons into the cortical plate is another possible cause of epileptogenesis. GABAergic
neurons are generated during early development in the ganglionic eminences, and failure
to pursue migration toward the cortex alters the excitatory/inhibitory balance resulting in
aberrant network hyperexcitability. More subtle defects in the developmental assembly of
excitatory and inhibitory synapses are also involved in epilepsy. For example, mutations in
the presynaptic proteins synapsins and SNAP-25 cause derangements of synaptic trans-
mission and plasticity which underlie appearance of an epileptic phenotype. Finally, there is
evidence that defects in synapse elimination and remodeling during early “critical periods”
can trigger hyperexcitability later in life. Further clariﬁcation of the developmental pathways
to epilepsy has important implications for disease prevention and therapy.
Keywords: cortex, hippocampus, GABA, glutamate, critical period, sodium channels
INTRODUCTION
Epilepsy is one of the most common neurological disorders, char-
acterized by the repeated occurrence of spontaneous bursts of
neuronal overactivity, known as seizures. Seizures typically arise
in restricted regions of the brain and may remain conﬁned to
these areas or spread to the whole cerebral hemispheres. The hip-
pocampal formation and cerebral cortex are considered the most
epileptogenic regions of the brain (Pitkanen and Sutula, 2002;
Avanzini and Franceschetti, 2003). The behavioral manifestations
of seizures, as well as the severity of the epileptic condition, strictly
relate to the brain regions that are affected by overactivity. Epilepsy
comprises a large group of syndromes with different etiologies. A
large series of recent studies demonstrated that several develop-
mental factors (including congenital brain malformations, altered
neuronal signaling during embryonic life, and defects in postnatal
maturation of neuronal networks) contribute to epileptogene-
sis, leading to the concept of epilepsy as a neurodevelopmental
disorder.
In the ﬁrst part of the review, we will focus on those alter-
ations in embryonic development of the cerebral cortex that lead to
an hyperexcitability phenotype in postnatal life. Taking examples
from both animal and human studies, we will describe the role of
a number of key developmental genes controlling the migration of
projection (excitatory) and local circuit (inhibitory) neurons, and
describe how their altered function may result in epileptogenesis.
In the second part of the review, we will describe the defects in
the developmental assembly of excitatory and inhibitory synapses
that are also involved in epileptogenesis. Speciﬁcally, we will focus
on defects in synapse elimination and remodeling during early
“critical periods” that may trigger hyperexcitability later in life.
The deep understanding of the complex developmental processes
involved in epileptogenesis may have important implications for
disease prevention and therapy.
DEVELOPMENTAL DEFECTS OF THE CEREBRAL CORTEX LEAD
TO EPILEPSY
The development of the mammalian cerebral cortex can be sub-
divided into three partially overlapping phases (Rubenstein, 2000,
2011; Lui et al., 2011). During the ﬁrst phase, stem cells located
in the ventricular and subventricular zones of the telencephalon
proliferate and differentiate into neuronal precursors or glial cells.
During the second phase, neurons migrate from their place of ori-
gin and reach their ﬁnal destination in the cerebral cortex (Marin
and Rubenstein, 2003; Kriegstein et al., 2006; Fishell, 2007; Fishell
and Hanashima, 2008). The mature cerebral cortex is organized in
six layers (Molyneaux et al., 2007) and contains two major types of
projection neurons. The vast majority (∼80%) are glutamatergic
(excitatory) neurons extending their long axon into the ipsilateral
or contralateral cortex (cortico-cortical neurons, located in layers
2/3) or toward subcortical regions (cortico-fugal neurons, located
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in layers 5/6). The remainder (∼20%) are GABAergic local circuit
neurons (inhibitory interneurons) that establish synaptic contacts
with excitatory neurons located in their proximity.
Migration of glutamatergic and GABAergic cortical neurons
occurs in two different ways. Glutamatergic projection neurons
are generated from neuronal precursors located in the neocortical
neuroepithelium via asymmetric cell divisions of cortical primary
progenitors (radial glia) located in the ventricular and subventric-
ular zones (Malatesta et al., 2003; Kriegstein et al., 2006; Hansen
et al., 2010). Asymmetric divisions generate immature projection
neurons, that migrate toward the cortical plate along radial glial
processes (Rakic, 2007) and hence reach their ﬁnal destination in
speciﬁc cortical layers through the interactionwith localmolecular
cues, such as Reelin (Frotscher, 2010). Cortical neurons are gener-
ated in an inside-out pattern, layer 6 neurons being the ﬁrst to be
born. The majority of GABAergic interneurons are instead gener-
ated outside of the cerebral cortex, in the ganglionic eminences of
the basal forebrain (Wonders andAnderson, 2006). The immature
interneurons initially migrate tangentially along the subventric-
ular zone of the basal forebrain, and then change direction by
following a radial or an oblique path to enter the cortical plate,
from where they reach their ﬁnal destination into the layers of the
cerebral cortex (Kriegstein and Noctor, 2004).
After completion of neuronal migration, the third, last phase
of cortical development involves a complex series of apoptotic
and synaptogenic events aimed at ﬁnely regulating the number of
mature neurons and their connections, ultimately leading to the
shaping of cortical circuits.
The embryonic development of the cerebral cortex is a complex
process, tightly controlled by a series of gene expression cascades
(Guillemot et al., 2006). Alterations of these gene regulatory path-
ways during development may lead to cortical malformations,
resulting in malfunction during postnatal life. Accordingly, sev-
eral cortical abnormalities have been identiﬁed that are caused by
mutations in key genes involved in the different phases of cortical
development. Cortical malformations may result from abnormal
neuronal proliferation, migration defects of both excitatory and
inhibitory neurons, or altered synaptogenesis/circuit formation,
and are usually epileptogenic (Barkovich et al., 2005; Guerrini and
Parrini, 2010; Manzini and Walsh, 2011).
Defects of neuronal and glial proliferation during embryonic
development result in epileptogenic cortical lesions. Tuberous
sclerosis complex (TSC) is a genetic disorder characterized by
the widespread development of benign tumors (hamartomas)
in multiple organ systems including the brain. Cortical tubers,
subependymal nodules, and subependymal giant cell astrocytomas
represent the typical lesions observed in TSC. These malforma-
tions result in early-onset seizures, that are often accompanied by
intellectual disability and autism. TSC results from mutations of
TSC1 (hamartin) orTSC2 (tuberin) genes that lead tohamartoma-
tous growths of neuronal and glial cells (Holmes and Stafstrom,
2007).
Neuronal migration disorders are a heterogeneous group
of neurological conditions characterized by abnormal neuronal
positioning in the cerebral cortex. Smooth cortex/lissencephaly
(absent or reduced convolutions resulting in cortical thickening
and smooth cerebral surface) and heterotopias (typically, ectopic
nodules of gray matter located in a periventricular or subcor-
tical position) have been associated to mutations in a number
of genes regulating cortical neuron migration and are character-
ized by severe neurological impairment and epilepsy (Guerrini
and Parrini, 2010). Migration defects of both excitatory and
inhibitory neurons contribute to these conditions and lead to
an altered excitation/inhibition balance and aberrant network
hyperexcitability.
Following the initial generation andmigrationof excitatory and
inhibitory neurons, immature neural networks are transformed
into organized circuits through a process of reﬁnement that is
largely controlled by electrical activity (Katz and Shatz, 1996).
During sensitive phases of the early postnatal life, called “critical
periods,” initially exuberant connections are eliminated and the
remaining synapses undergo a functional maturation (Katz and
Shatz, 1996; Berardi et al., 2000). Perturbations in this develop-
mental reﬁnement of neuronal circuitry during critical periods
may trigger hyperexcitability and epilepsy later in life. In the
following sections,we will detail some of the most signiﬁcant mol-
ecular mechanisms involved in neuronal proliferation, neuronal
migration, and synaptic reﬁnement (schematically illustrated in
Figure 1 and summarized in Table 1), whose perturbation during
embryonic or postnatal development results in epileptogenesis.
NEURONAL PROLIFERATION DEFECTS
Tuberous sclerosis complex is a neurocutaneous syndrome char-
acterized by benign tumors, early-onset epilepsy, intellectual dis-
ability, and autism (Holmes and Stafstrom, 2007). TSC results
from loss-of-function mutations of TSC1 or TSC2 genes, which
are crucially involved in the control of neuronal and glial cell pro-
liferation during embryonic development. TSC1 encodes a pro-
tein (hamartin) containing two coiled-coil domains, while TSC2
encodes a GTPase activating protein (tuberin) that inhibits small
G-proteins belonging to the Ras-related super-family. Hamartin
and tuberin are both expressed in neurons and astrocytes of spe-
ciﬁc central nervous system (CNS) regions such as forebrain, cere-
bellum, and brainstem, where they form a protein–protein com-
plex that constitutively inhibits mammalian target of rapamycin
(mTOR), a serine–threonine kinase positively regulating protein
synthesis, cell proliferation, and survival. The function of the
TSC1/2 complex is controlled by multiple intracellular signaling
pathways converging on AKT, a pro-survival and pro-oncogenic
kinase that directly phosphorylates TSC2 inhibiting its function.
Loss of TSC1/2 function leads to activation of the mTOR cascade
and results in increased cell proliferation; conversely, inhibition of
mTOR function (e.g., by rapamycin) results in growth suppres-
sion and reduced cell size (Jozwiak, 2006; Holmes and Stafstrom,
2007). The occurrence of tubers in animal models of TSC has been
a point of controversy in the ﬁeld. In contrast with the main fea-
ture of the human disease,Tsc1+/− orTsc2+/− mice do not develop
tubers (Kobayashi et al., 2001;Uhlmann et al., 2002;Goorden et al.,
2007; Ehninger et al., 2008; Bonnet et al., 2009). However, condi-
tional inactivation of Tsc1 or Tsc2 in astrocytes leads to tuber-like
lesions and severe seizures in mice (Zeng et al., 2008, 2011; Way
et al., 2009). More recently, in utero electroporation was used to
induce homozygous (Tsc1−/−) cell clones on a TSC1 heterozygous
(Tsc1+/−) background. This strategy resulted in cortical tuber-like
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FIGURE 1 | Genes involved in neurodevelopmental causes of epilepsy.
The picture shows a schematic time-line of the most signiﬁcant gene
functions involved in neuronal proliferation, neuronal migration, and synaptic
reﬁnement, whose perturbation during embryonic or postnatal development
results in epileptogenesis (see text andTable 1 for details). Abbreviations are
as in the text.
lesions and a lower seizure threshold, suggesting that cells inside
the tubers might have an additional somatic mutation that might
contribute to the pathological phenotype (Feliciano et al., 2011).
These studies clearly indicate that altering TSC1/2 signaling in spe-
ciﬁc CNS cell types is at the origin of TSC, but also point out the
difﬁculty of modeling TSC in mice.
The histopathological features of cortical tubers in TSC reﬂect
the antiproliferative role normally exerted by the TSC1/2 signal-
ing complex. Cortical tubers in TSC patients are characterized
by giant, dysplastic, and heterotopic neurons with aberrant den-
drites and axons, as well as by proliferating astrocytes (Holmes
and Stafstrom, 2007). Cortical hyperexcitability arises in the prox-
imity of tubers, but its causes remain largely unknown (Major
et al., 2009). Several hypotheses have been proposed to explain
epileptogenesis in TSC. Increased expression of NMDA glutamate
receptors and decreased expression of the GABA synthetic enzyme
glutamic acid decarboxylase (GAD65), GABA vesicular trans-
porter (vGAT), and GABA receptor subunits have been described
in cortical tubers from human TSC patients (White et al., 2001),
suggesting that excitation/inhibition imbalance in cortical circuits
may contribute to epileptogenesis. Another intriguing hypothe-
sis is that cortical tubers may alter thalamocortical connectivity
during early brain development, thus resulting in hyperexcitable
cortical circuits (Holmes and Stafstrom, 2007).
Seizure suppression in TSC remains a difﬁcult task to be
achieved. Infantile spasms in TSC often respond to vigabatrin
(a GABA-transaminase inhibitor), but not to other antiepileptic
drugs (AEDs), and the surgical removal of tubers remains in many
cases the only therapeutic option (Holmes and Stafstrom, 2007).
For these reasons, much emphasis has been put to the potential
beneﬁcial effects of the mTOR inhibitor rapamycin as a novel
anticonvulsant and antiepileptogenic drug. Indeed, rapamycin
is able to reduce seizures and prevent epileptogenesis in vari-
ous animal models. For example, rapamycin treatment blocked
epilepsy progression in conditional mutant mice lacking TSC1 or
the TSC-positive regulator PTEN (Zeng et al., 2008; Sunnen et al.,
2011), and reversed learning deﬁcits in a Tsc2+/− mice (Ehninger
et al., 2008). Importantly, rapamycin administered to chronically
epileptic rats following kainic acid (KA; Zeng et al., 2009) or pilo-
carpine (Huang et al., 2010) treatment has been shown to suppress
acquired epilepsy, even though these results have not been repli-
cated inmice (Buckmaster andLew,2011).However, some authors
pointed out that rapamycin treatment in animal models is still far
to be optimal, since seizures may reappear after treatment ces-
sation, and continuous rapamycin exposure might severely affect
animal growth and health (Sunnen et al., 2011). In this respect,
valid alternative strategies might be represented by a high-dose
pulse treatment (Raffo et al., 2011) or even prenatal exposure (to
be applied in cases of familial TSC predisposition; Anderl et al.,
2011), that have been successfully tested in rodents. According to
these results obtained in animal models, preliminary ﬁndings in
human patients are encouraging: rapamycin has been shown to
induce the regression of astrocytomas in a small group (n = 5) of
TSC cases (Franz et al., 2006), and to reduce seizure frequency
in a single young TSC patient (Muncy et al., 2009). However,
it is important to point out that while the effects of rapamycin
on tumor growth in TSC patients are now well documented and
reproduced in many cases, its efﬁcacy on seizure control and other
neurological deﬁcits needs to be further investigated.
MIGRATION DEFECTS OF CORTICAL PROJECTION NEURONS
The classiﬁcation and neuropathological features of genetic neu-
ronal migration disorders have been described in other reviews
(Guerrini and Marini, 2006; Guerrini and Parrini, 2010). Dif-
ferent forms of lissencephaly (“smooth brain”) and heterotopias
have been associated to mutations in genes involved in cortical
neuron migration (LIS1, DCX, ARX, TUBA1A, RELN, FLNA, and
ARFGEF2). Here we will focus on two of these genes, doublecortin
(DCX) and reelin (RELN), whose function in neuronal migration
and epilepsy has been investigated in more detail.
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DOUBLECORTIN
Dominant, X-linked DCX mutations cause lissencephaly or sub-
cortical band heterotopia (SBH; “double cortex”), syndromes
characterized by mental retardation and epilepsy in humans.
Speciﬁcally, DCX mutations cause lissencephaly in hemizygous
males, whereas heterozygous females show a mosaic phenotype
with a normal cortex and a second band of heterotopic neu-
rons beneath the cortex (“double cortex”; des Portes et al., 1998;
Matsumoto et al., 2001). DCX encodes a 40-kDa microtubule-
associated protein (doublecortin) expressed in migrating neu-
roblasts and containing two conserved tandem repeats required
for tubulin binding and microtubule stabilization (des Portes
et al., 1998; Gleeson et al., 1998; Gleeson and Walsh, 2000).
How doublecortin inﬂuences microtubule dynamics during brain
embryonic development remains largely unclear.
Mice lacking Dcx (hemizygous Dcx−/Y male and heterozygous
Dcx+/− female mice) have been generated in the attempt to repro-
duce thehumanphenotypeof DCXmutations (Corbo et al.,2002).
Dcx−/Y male mice present hippocampal lamination defects and a
reduced number of hippocampal interneurons, but have no gross
anatomical defects at the level of the cerebral cortex (Corbo et al.,
2002; Nosten-Bertrand et al., 2008). Similar defects are observed
also in Dcx+/− female mice. Importantly, Dcx−/Y male mice have
hippocampal-dependent learning deﬁcits (Corbo et al., 2002), are
hyperexcitable and show spontaneous seizures with hippocampal
onset (Nosten-Bertrand et al., 2008).
Severe migration defects of cortical projection neurons and
cortical malformation have been instead detected in mice lacking
both doublecortin and doublecortin-like kinase 1 (Dclk1; Deuel
et al., 2006; Koizumi et al., 2006; Kerjan and Gleeson, 2007). More
importantly, Dcx RNA interference (RNAi) performed by in utero
electroporation results in migration defects of pyramidal corti-
cal neurons and spontaneous seizures in adult rats (Bai et al.,
2003; Ackman et al., 2009; Lapray et al., 2010), similar to those
observed in human SBH. Manent et al. (2009) tested whether the
postnatal re-expression of Dcx could rescue these anatomical and
neurological deﬁcits. To this aim, the Dcx knockdown RNAi vec-
tor was in utero electroporated into cortical neurons together with
a tamoxifen-inducible Dcx expression vector system. In this way,
it was possible to knockdown Dcx in cortical neurons at embry-
onic day (E)14 and then re-activate it between postnatal day (P)0
and P10 by treating newborn pups with tamoxifen. Postnatal re-
expression of Dcx induced in this way was able to reduce neuronal
migration defects and seizures in this model of SBH (Kerjan and
Gleeson, 2009; Manent et al., 2009).
Dcx and doublecortin-like kinase have also been implicated
in the migration of cortical interneurons (Friocourt et al., 2007;
see section below). Taken together, these data indicate that dou-
blecortin is required for hippocampal lamination as well as
migration of neocortical pyramidal neurons and interneurons;
as a consequence of this important role, an altered function of
doublecortin during embryonic forebrain development results in
epilepsy in the postnatal life.
REELIN
Mutation of the RELN gene, coding for the extracellular gly-
coprotein Reelin, causes a neuronal migration disorder called
lissencephaly with cerebellar hypoplasia (Zaki et al., 2007; Guer-
rini and Parrini, 2010). Reelin binds several receptors, including a
complex composed by the apolipoprotein E receptor 2 (ApoER2)
and the very low-density lipoprotein receptor (VLDLR) (Honda
et al., 2011). Following receptor binding, Reelin activates the
intracellular proteinDisabled homolog 1 (Dab1),whose phospho-
rylation enhances signal transduction pathways leading to axonal
growth, neuronal migration, and synaptic plasticity (Frotscher,
2010; Honda et al., 2011). Reelin-activated pathways include the
PI3K/Akt/Gsk-3β andNotch cascades (Honda et al., 2011).During
embryonic development, Reelin is mainly expressed by Cajal–
Retzius cells in the marginal zone of the neocortex and outer
molecular layer of the hippocampus,whereas in the adult brain it is
expressed inGABAergic interneurons (Alcantara et al., 1998).Mice
lackingReelin (reeler mice) showadramatic impairment of migra-
tion of cortical projection neurons, that results in a highly disorga-
nized and dyslaminated cerebral cortex (D’Arcangelo and Curran,
1998; D’Arcangelo, 2006). The ﬁnal outcome is an increased sus-
ceptibility to hippocampal and neocortical epileptiform activity
(Patrylo et al., 2006). During embryogenesis, the ﬁrstly generated
cortical neurons migrate from the germinal zone and form the
preplate. At the arrival of subsequently generated neurons, the
preplate splits into two layers: the Cajal–Retzius layer (expressing
Reelin) and the subplate. Successive waves of neurons migrate past
the subplate, but not past the Cajal–Retzius layer, that will form the
most superﬁcial layer of the mature cerebral cortex. In the absence
of Reelin, neuronal migration does not occur properly and neo-
cortical lamination is perturbed. The preplate does not split, and
newly generated neurons pile up behind the previously generated
ones, resulting in an inverted layering of the neocortex. Several
hypotheses have been proposed to explain the role of Reelin in
neuronal cortical migration: (i) Reelin might function as a chemo-
attractant for migrating neurons; (ii) it might control the preplate
splitting that initiates the inside-out lamination; (iii) it might
determine the detachment of neurons from radial glial processes
and their subsequent differentiation (D’Arcangelo and Curran,
1998; Cooper, 2008; Gaiano, 2008). More recent studies suggest
that Reelin and Notch signaling cooperate to regulate neuronal
migration in the neocortex (Hashimoto-Torii et al., 2008).
Reelin is also implicated in the migration of excitatory neurons
of the hippocampus; a marked dispersion of projection neurons
is observed in the stratum pyramidale and dentate granule cell
layer in reeler mice (D’Arcangelo and Curran, 1998). Granule cell
dispersion (GCD) is often observed in human mesial temporal
lobe epilepsy (MTLE), and recent studies investigated the role
of Reelin in this form of epileptic condition. In the adult hip-
pocampus, Reelin-positive interneurons (Cajal–Retzius cells) are
normally found in theCA1andCA3 regions, in the hilus, and along
the hippocampal ﬁssure, both in mouse (Heinrich et al., 2006) and
human samples (Haas et al., 2002). Indeed, GCD correlates with
hippocampal Reelin loss in MTLE patients, as shown by stud-
ies performed on hippocampal tissues resected from adult sub-
jects who underwent temporal lobectomy for intractable MTLE
(Haas et al., 2002). GCD and loss of Reelin was also observed in
rodent models of MTLE (Heinrich et al., 2006; Gong et al., 2007;
Antonucci et al., 2008, 2009; Duveau et al., 2010). The causative
role of Reelin deﬁciency in GCD is conﬁrmed by the observation
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that GCD is induced by the infusion of Reeling-blocking anti-
body, and prevented by the administration of exogenous Reelin
(Haas and Frotscher, 2010). It remains still to be determined how
Reelin loss and subsequent GCD contribute to epileptogenesis,
and whether they are a cause or an effect of seizures (Haas and
Frotscher, 2010).
MIGRATION DEFECTS OF CORTICAL INTERNEURONS
Cortical GABAergic interneurons are generated in ganglionic
eminences of the basal forebrain, from where they migrate to
reach their ﬁnal location (Wonders and Anderson, 2006). Sev-
eral genes have been implicated in interneuron differentiation and
migration; the role of speciﬁc interneuron types in epilepsy is a
developing ﬁeld, which may help us to better understand the com-
plex neurodevelopmental processes underlying seizure onset and
control. Here we will focus on Dlx, Arx, Dcx, and Reelin genes,
whose role in interneuron migration and possible implications in
epileptogenesis has been extensively studied in mouse models.
Dlx
Migration and differentiation of cortical GABAergic interneu-
rons has been shown to depend on the action of Dlx homeobox
transcription factors, namely Dlx1/2 and Dlx5/6. Dlx genes are
expressed in GABAergic neuron progenitors of the developing
forebrain and in subsets of mature GABAergic interneurons of
the adult cerebral cortex (Cobos et al., 2005b, 2007; Wang et al.,
2010). Loss-of-function mutations of pairs of mouse Dlx genes
(Dlx1/2 or Dlx 5/6) severely affect the migration and differenti-
ation of distinct subpopulations of cortical interneurons. Specif-
ically, Dlx1/2 have a crucial role in the migration and survival of
calretinin (CR), somatostatin (SOM), and neuropeptide Y (NPY)
positive interneurons (Anderson et al., 1997; Cobos et al., 2005b,
2007) whereas Dlx5/6 preferentially control parvalbumin-positive
interneurons (Wang et al., 2010).
Migration defects and subsequent reduced number of cortical
interneurons result in epilepsy in Dlx mutant mice. Mice lack-
ing Dlx1 (Dlx1−/− mice) show selective apoptotic cell death of
CR, SOM, and NPY cortical interneurons, resulting in decreased
synaptic inhibition at 1month of age. Accordingly, adult Dlx1−/−
mice show noise- or handling-induced behavioral seizures and
generalized electrographic activity (Cobos et al., 2005b). Mice
homozygous for both Dlx5 and Dlx6 (Dlx5/6−/− mice) show a
normal layering of the cerebral cortex and a normal positioning of
MGE-derived cortical interneurons, but die perinatally. A reduced
number of PV cortical interneurons is observed in these mutants,
and the surviving PV interneurons show an increased dendritic
branching (Wang et al.,2010).Conversely,heterozygousDlx5/6+/−
mice do not present interneuron loss nor other gross anatomical
abnormalities, but develop epilepsy; this has been ascribed to func-
tional deﬁcit and aberrant connectivity of PVneurons (Wang et al.,
2010).
Taken together, these studies clearly demonstrate thatDlx genes
regulate the development and function of forebrain interneu-
rons, which are crucial to maintain the inhibitory tone of the
cerebral cortex and other brain structures. The reduced function
of Dlx transcription factors (or of their transcriptional targets,
such as GAD and vGAT; Stuhmer et al., 2002; Rubenstein, 2011)
might increase the excitation/inhibition ratio thus predisposing
the cerebral cortex to hyperexcitability and epilepsy.
Arx
The aristaless-related homeobox gene (Arx) belongs to the family
of paired-class homeobox transcription factors, and its expression
is controlled by the Dlx genes in cells derived from basal gan-
glia progenitor domains (Cobos et al., 2005a). Arx plays a pivotal
role in the development of the CNS. ARX large deletions, protein
truncating mutations and missense mutations in the homeobox
region lead to X-linked lissencephaly with abnormal genitalia,
while other ARX mutations cause intellectual disability, autism,
and epilepsy without cortical malformations (Kitamura et al.,
2002). Arx expression has been detected in the developing lateral
and medial ganglionic eminence and later in cortical progenitors
and migrating interneurons (Colombo et al., 2004; Friocourt et al.,
2006). Studies in animal models showed that Arx is critical for
radial migration of cortical progenitors and is crucially involved
in the development and migration of GABAergic interneurons
(Colombo et al., 2007; Friocourt et al., 2008; Marsh et al., 2009).
In Arx-null embryos, interneuron migration from the lateral and
medial ganglionic eminences is nearly absent, whereas migration
through the cortical layers is only partially impaired. As a conse-
quence, CR, NPY, and calbindin (CB) interneurons are severely
reduced (Kitamura et al., 2002; Colombo et al., 2007). No loss
of PV interneurons was instead observed in hemizygous Arx−/−
mice suggesting the Arx loss results in speciﬁc interneuron sub-
type deﬁcits (Friocourt and Parnavelas, 2010). These studies also
revealed that abnormal expression of transcription factors poten-
tially important for neuronal differentiation and migration occurs
in Arx−/− mice.
Dcx
Cortical interneuron migration is also controlled by both Dcx and
Dclk. Dcx knockdown by RNAi slows the migration of interneu-
rons from the ganglionic eminence to the cerebral cortex (Frio-
court et al., 2007), and cortices of Dcx,Dclk, and Dcx/Dclk mutant
mice contain less CB-positive interneurons as compared to con-
trol mice (Friocourt et al., 2007; Nosten-Bertrand et al., 2008). An
increased number of CR-positive interneurons is detected in the
dentate gyrus of Dcx mutant mice (Nosten-Bertrand et al., 2008),
whereas no defects of PV interneurons are detected in Dcx, Dclk,
and Dcx/Dclk mutant mice (Kerjan and Gleeson, 2009).
REELIN
A large subset of cortical and hippocampal GABAergic interneu-
rons express Reelin. These interneurons derive from the caudal
ganglionic eminence (CGE), and occupy superﬁcial layer of the
cerebral cortex (Miyoshi et al., 2010) and strata lacunosum mol-
eculare and deep radiatum of the mature hippocampus (Tricoire
et al., 2011). The role of Reelin in interneuron migration and posi-
tioning in forebrain areas has been debated. Some authors showed
that in reeler mice,GABAergic interneuronsmigrate normally into
the developing forebrain, but fail to acquire proper layer posi-
tion in the mature cerebral cortex (Hammond et al., 2006; Yabut
et al., 2007). Using transplants to analyze themechanisms underly-
ing the positioning of cortical interneurons, other authors instead
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found that layer acquisition by these cells does not directly depend
on Reelin signaling (Pla et al., 2006). Interestingly, a recent study
showed that neuronal activity is essential for the migration and
morphology of CGE-derived Reelin- and CR-positive interneu-
rons (De Marco García et al., 2011). To suppress excitability in
CGE-derived interneurons, the authors electroporated in utero
the inward rectifying potassium channel Kir2.1 under the con-
trol of a Dlx5/6 enhancer element at E15.5, and then analyzed
the positioning and morphology of Reelin and CR interneurons.
Results showed that neuronal activity is required before P3 for
the correct migration of CGE-derived interneurons, and that after
P3, glutamate-mediated activity controls the development of their
connections (DeMarcoGarcía et al., 2011). These ﬁndings indicate
that the genetic program underlying the development of Reelin-
expressing interneurons is stronglymodulated by activity, andmay
have implications for the role of Reelin in neurodevelopmental
epileptic syndromes.
GABA AND GLUTAMATE CONTROL NEURONAL MIGRATION
IN THE FOREBRAIN
Studies performed on corticohippocampal organotypic co-
cultures from EGFP-expressing mouse embryos demonstrated
that GABA and glutamate may modulate neuronal migration in
the developing forebrain. Speciﬁcally, GABA and glutamate mod-
ulate the migration of hippocampal pyramidal neurons respec-
tively acting on GABAA and NMDA receptors (Manent et al.,
2005), while glutamate controls the migration of GABAergic
interneurons via AMPA receptor activation (Manent et al., 2006).
These results led the authors to postulate that the migrations of
glutamatergic and GABAergic interneurons are inter-dependent:
glutamate released from pioneer glutamatergic neurons controls
the migration of GABAergic interneurons, which in turn would
facilitate glutamate neuron migration via GABA release (Manent
and Represa, 2007). In keeping with these observation, the same
authors showed that prenatal exposure to some AEDs acting on
GABA signaling (such as vigabatrin, valproate, and lamotrigine)
results in hippocampal and cortical dysplasias in the developing
embryos (Manent et al., 2007, 2008), thus raising serious concerns
about the possible consequences of AEDs use during pregnancy.
DEVELOPMENTAL REMODELING OF NEURONAL CIRCUITS
In the previous sections we have considered how defects in the
early stages of brain development (i.e., neuronal proliferation
and migration) can induce an epileptic phenotype. Following the
initial assembly of excitatory and inhibitory neurons, immature
neural networks are transformed into organized circuits that sub-
serve adult brain function (Katz and Shatz, 1996). This process
of network reﬁnement is largely controlled by electrical activity.
In particular, work in the sensory cortices has clearly established
the existence of so-called “critical periods,” during which patterns
of activity generated by sensory experience play a critical role for
maturation of cortical function (Berardi et al., 2000). During these
sensitive phases of development, initially exuberant connections
are eliminated andneuronal dendrites are correspondingly pruned
and narrowed. The remaining synapses functionally mature (Katz
and Shatz, 1996). In particular, in the visual system, synapse elimi-
nation and remodeling depends upon the amount and patterning
of neural activity within the visual pathway (Fagiolini et al., 1994;
Caleo et al., 2007).
Perturbations in this developmental reﬁnement of neuronal
circuitry during critical periods may trigger hyperexcitability and
epilepsy later in life. One clear example comes from a study on
blockade of hippocampal activity during early development (Gal-
van et al., 2000). In the rodent hippocampus, CA3 pyramidal
neurons display an exuberant growth of axon collaterals during
postnatal weeks 2 and 3; this developmental time period corre-
sponds to a critical phase, when CA3 networks have a marked
propensity to generate epileptic seizures (Swann and Brady, 1984).
Exuberant CA3 axons are then remodeledwithmaturation, so that
about half of the branches are eliminated (Gomez-Di Cesare et al.,
1997). To prevent this axonal remodeling, Swann and colleagues
infused tetrodotoxin (a blocker of voltage-gated sodium chan-
nels) into the rat hippocampus for about 10 days starting from
P12 (Galvan et al., 2000). This transient blockade of neuronal
activity resulted in the establishment of a chronic epileptic focus
in adulthood, with prolonged electrographic seizures originating
from the infused hippocampus (Galvan et al., 2000). These results
are consistent with the idea that blockade of neuronal activity dur-
ing early critical phases can enhance seizure susceptibility later in
life by preventing developmental remodeling of neural circuits.
Indeed, the immature brain is more prone to seizures than the
adult brain (Ben-Ari and Holmes, 2006).
Recently, a persistent immaturity of glutamatergic circuitries in
the hippocampus was found to underlie seizure susceptibility in
autosomal dominant lateral temporal lobe epilepsy (ADLTE;Zhou
et al., 2009). This study investigated the function of LGI1 (leucine-
rich, glioma-inactivated 1), a gene that is implicated in about half
the cases of ADLTE (Kalachikov et al., 2002; Striano et al., 2011).
LGI1 encodes a protein that localizes to glutamatergic synapses,
binds its receptors ADAM22 and ADAM23 (disintegrin and met-
alloproteinase domain 22 and 23), and copuriﬁes with presynaptic
and postsynaptic regulatory molecules (Fukata et al., 2006; Schulte
et al., 2006). LGI1 expression increases in the rodent hippocam-
pus exactly during the third postnatal week, when glutamatergic
synapses are pruned and mature (Fukata et al., 2006; Zhou et al.,
2009). In particular, excitatory neurons downregulate their presy-
naptic vesicular release probability and reduce their postsynaptic
NMDA-receptor subunit NR2B; during this same period, den-
dritic arbors and spines are pruned and remodeled. Anderson and
colleagues generated mice expressing a truncated form of the LGI1
gene, found inADLTEpatients, and showed that hippocampal glu-
tamatergic synapses did not properly mature in these mice (Zhou
et al., 2009). Speciﬁcally, (i) the normal, age-dependent decrease of
probability of glutamate release was blocked in mutant mice; (ii)
developmental changes in glutamate receptor composition were
impaired by mutated LGI1; and (iii) dendrites of adult mutant
mice remained immature, with a high density of branches and
spine protrusions (Zhou et al., 2009). Importantly, mutant LGI1
mice displayed a lower threshold for the development of phar-
macologically induced seizures. There was no signiﬁcant effect
of mutated LGI1 on GABAergic neurotransmission (Zhou et al.,
2009; Yu et al., 2010). All together, these data suggest that mutated
LGI1 blocks the normal functional maturation of both presynap-
tic and postsynaptic compartments and halts structural pruning,
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thus maintaining a high density of excitatory synaptic inputs
converging onto hippocampal neurons and leading to a hyperex-
citability phenotype (Caleo, 2009; Zhou et al., 2009).Other reports
are consistent with the idea that LGI1 regulates the development
of glutamatergic synapses (Fukata et al., 2010; Yu et al., 2010).
In keeping with this ﬁndings, recent data show that heterozy-
gous mice lacking LGI1 (LGI1+/− mice) display a lower threshold
to auditory stimuli induced seizures, and homozygous LGI1−/−
mice develop spontaneous recurrent seizures followed hippocam-
pal neuronal loss, mossy ﬁber sprouting, astrocyte reactivity, and
GCD (Chabrol et al., 2010).
EPILEPTOGENIC ION CHANNEL MUTATIONS: FOCUS ON
SCN2A
In the last years, a number of epileptogenic mutations have been
identiﬁed in different genes (Noebels, 2003). The majority of these
genes code for voltage- or ligand-gated ion channels. Mutations
in different subunits of sodium, potassium, and calcium channels
underlie different forms of genetic epilepsies (“channelopathies”;
Kullmann, 2010; Mantegazza et al., 2010). Mutations of the nico-
tinic acetylcholine receptor subunits are associatedwith autosomal
dominant nocturnal frontal lobe epilepsy (De Fusco et al., 2000).
Mutations in the voltage-gated potassium channel subunit genes
KCNQ2 and KCNQ3 are associated with benign familial neona-
tal seizures (Leppert and Singh, 1999). Mutations in the GABAA
receptor, which is the primary mediator of synaptic inhibition,
have also been found to contribute to several idiopathic epilep-
sies and febrile seizures (Galanopoulou, 2010). The functional
consequences of these epileptogenic mutations have been amply
studied, and the data have provided signiﬁcant knowledge on the
pathogenic mechanisms that lead to epilepsy. For more details on
these ﬁndings, the reader is referred to a series of excellent reviews
(Noebels, 2003; Kullmann, 2010; Mantegazza et al., 2010).
Mutations in voltage-gated sodium channel genes (Nav) are
the most common genetic cause of familial epilepsy. Speciﬁcally,
mutations in the Nav1.1 alpha subunit gene (SCN1A) are respon-
sible for “generalized epilepsy with febrile seizures plus” (GEFS+;
Scheffer and Berkovic, 1997) and Dravet’s syndrome (Mantegazza
et al., 2010; Meisler et al., 2010). Missense mutations in Nav1.2
alpha subunit (SCN2A) are found in patients with benign familial
neonatal-infantile convulsions (Avanzini et al., 2007). Functional
studies demonstrate that Nav1.2 mutations result in modiﬁcations
of the gating properties of the channel, with a net ampliﬁcation of
the sodiumcurrent and resulting greater depolarization,consistent
with the hyperexcitability phenotype (Scalmani et al., 2006).
It is important to point out that it is often difﬁcult to predict the
epileptic phenotype based solely from the change in the behavior
of the mutated channel. First, it is crucial to determine cell-speciﬁc
patterns of expression of the mutated subunit, as expression in
excitatory vs. inhibitory neurons can lead to completely opposite
effects on excitability status of the neuronal network (Yu et al.,
2006). Second, the cellular background (i.e., the modiﬁer effect
of other channels expressed in the same neuron) has to be con-
sidered (Glasscock et al., 2007). “Humanized” mouse models (in
which human mutated channel sequences are inserted in geneti-
cally engineered mice) offer an unique opportunity to study the
modulatory role of the genetic background and of the interactions
between different genes. One example is represented by transgenic
mice (Q54) carrying a human, epileptogenicmissensemutation of
the sodium channel SCN2A (Nav1.2; Kearney et al., 2001). Mice
carrying the Q54 transgene on a SJL strain background exhibit
severe spontaneous seizures originating in the hippocampus with
onset at about 4weeks, and progressive hippocampal sclerosis with
extensive cell loss and gliosis in areas CA1, CA3, and hilus (Kear-
ney et al., 2001; Manno et al., 2011). However, on a pure C57BL/6J
background, onset of seizures is delayed and the epileptic phe-
notype is mild. Two modiﬁer loci responsible for the difference in
severity between strains C57BL/6J and SJL have been mapped, and
the evidence points to the voltage-gated potassium channel gene
Kcnv2 as onemodiﬁer (Bergren et al., 2005,2009). These data indi-
cate that severity of the epileptic condition may be signiﬁcantly
impacted by gene interactions.
Finally, in the study of channelopathies it is important to
underlie the possible effects of the complex interaction between
mutated genes and the environment. As we have described in the
previous section, early environmental conditions shape neuronal
connectivity, and the resulting changes in network organization
can potently affect clinical expression of a mutated channel. In
keepingwith this notion,Q54 transgenicmice (carrying an epilep-
togenic mutated SCN2A; see above) exposed to environmental
enrichment from birth show a dramatic reduction of spontaneous
seizures and hippocampal cell loss (Manno et al., 2011). The data
indicate that an enriched housing from birth may have profound
antiepileptic and neuroprotective effects. Environmental enrich-
ment may exert these actions by up-regulation of neurotrophic
factors, plastic rearrangements in excitatory/inhibitory circuits,
and stimulation of neurogenesis (Dhanushkodi and Shetty, 2008;
Sale et al., 2009). Thus, changes in network organization due
to environmental inﬂuences can halt epileptogenic changes and
dampen hyperexcitability of neural networks.
EPILEPTOGENIC ALTERATIONS OF PRESYNAPTIC PROTEIN
FUNCTION
In addition to channelopathies, defects in the control of neuro-
transmitter release account for a wide variety of epileptic syn-
dromes. Presynaptic proteins that have been found to be involved
in epilepsy include the synaptic vesicle (SV) protein SV2A (Crow-
der et al., 1999; Janz et al., 1999), the SV-anchoring phosphopro-
teins synapsins (Rosahl et al., 1995; Baldelli et al., 2007) and the
plasma membrane fusion protein SNAP-25 (Zhang et al., 2004).
Not all disruptions of the neurotransmitter machinery are equally
epileptogenic, as shownby the lackof seizures inmice lackingother
presynaptic proteins, such as synaptotagmin (Fernandez-Chacon
et al., 2001) or synaptobrevin/VAMP (Schoch et al., 2001). Data
obtained in mice mutant for synapsins and SNAP-25 are partic-
ularly interesting, since they suggest that hyperexcitability might
result from developmental alterations causing an unbalance in the
activity of excitatory and inhibitory neurons.
SYNAPSINS
Synapsins (Syns) comprise a family of neuron-speciﬁc proteins
encoded by three distinct genes (SYNI, SYNII, and SYNIII) located
in chromosome X, 3, and 22, respectively. The Syns are phospho-
proteins implicated in the regulation of neurotransmitter release
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and synapse formation. In particular, Syns are responsible for the
formation and maintenance of SV pools within the nerve termi-
nal (Benfenati et al., 1992) and their expression has been causally
related to the formation and maturation of synaptic connectiv-
ity during neural development and synaptogenesis (Valtorta et al.,
1995; Bonanomi et al., 2005). Despite the absence of gross defects
in brain morphology, Syn I and Syn II (but not Syn III) knockout
(KO) mice exhibit early-onset spontaneous and sensory stimuli-
evoked epileptic seizures (Rosahl et al., 1995). Syn I mutations can
also contribute to human epilepsy (Garcia et al., 2004). In Syn
KO mice, spontaneous recurrent seizures develop after 2months
of age and the animals become more susceptible with age (Rosahl
et al., 1995). This latent period of “epileptogenesis” suggests that
alterations in the developmental assembly of neural networks may
underlie hyperexcitability in these mice.
Several theories have been put forward to explain the nexus
between the molecular function of Syns at the neuronal level and
the onset of the epileptic phenotype. Since Syns are involved in
crucial steps of presynaptic physiology and play a role in the for-
mation of the synaptic connectivity during development, it is likely
that mutations affecting their expression and/or phosphorylation-
dependent functions will result in signiﬁcant changes in synaptic
transmission, plasticity and development which could be poten-
tially related to the appearance of an epileptic phenotype. Thus,
the epileptic phenotype of Syn KO animals might be due to a
defect in the overall brain connectivity (Chin et al., 1995), or to
an impairment in synaptogenesis within conﬁned neuronal pop-
ulations (Gitler et al., 2004; Bonanomi et al., 2005). There is also
support for the idea that lack of Syns produces an imbalance in
the activity of excitatory and inhibitory neurons. Indeed, Syn I
KO reduces the readily releasable pool at inhibitory synapses, and
increases it at excitatory synapses (Baldelli et al., 2007;Chiappalone
et al., 2009).
SNAP-25
A further example of presynaptic protein involved in epilepsy
is SNAP-25. SNAP-25, together with syntaxin and synapto-
brevin/VAMP, is amember of the SNARE (solubleNSF attachment
protein receptor) complex which contributes to the formation of
the fusion complex required for SVexocytosis. Besideparticipating
in SV fusion, SNAP-25 has been proposed to regulate exocytosis at
additional steps. Through its interaction with other proteins, such
as synaptotagmin or complexins (Jahn et al., 2003) or through
putative calcium binding sites (Sorensen et al., 2002), SNAP-25
appears to participate in the calcium-dependent regulation of exo-
cytosis. SNAP-25 has also been shown to interact with and mod-
ulate the activity of various voltage-activated calcium channels
(Atlas, 2001; Pozzi et al., 2008; Condliffe et al., 2010). The pos-
sible involvement of SNAP-25 in neuronal hyperexcitability and
epilepsy comes from the neurological mouse mutant Coloboma
(Cm/+), bearing an autosomal dominant deletion on chromo-
some 2, including the SNAP-25 gene (Hess et al., 1992, 1994).
Cm/+ mice show 50% reduction in SNAP-25 mRNA and protein,
and impaired evoked neurotransmitter release (Raber et al., 1997;
Wilson, 2000). Interestingly, Cm/+ mice show robust cortical cor-
tical spike-wave discharges and increased thalamic T-type currents
(Zhang et al., 2004), two typical features of “absence” epilepsy
(Tsakiridou et al., 1995; Coenen and Van Luijtelaar, 2003).
Similarly to what already described for Syns, the role of SNAP-
25 in the etiopathology of epilepsy may involve alterations of
synaptic formation/reﬁnement during development. The epilep-
tic phenotype of SNAP-25 mutant mice may be produced by a
defect in the overall brain connectivity consequent to the reduced
expression of the protein, which is known to play a crucial role in
neurite extension (Osen-Sand et al., 1996). Alternatively, it may be
the consequence of unbalances in neurotransmitter release due to
deﬁcits in the SNAREcomplex. Interestingly, SNAP-25 is expressed
at much higher levels at excitatory vs. inhibitory synapses (Verde-
rio et al., 2004; Bragina et al., 2007). Thus, hyperexcitability
could result from perturbations of the processes that balance the
developmental assembly of inhibitory and excitatory circuits. Fur-
thermore, recent studies have shown a role of SNAP-25 in the
regulation of calcium homeostasis in neurons. In particular, it has
been shown that phosphorylated SNAP-25 negatively modulates
calcium dynamics by inhibiting voltage-gated calcium channels
(Verderio et al., 2004; Pozzi et al., 2008). Thus, reduced levels of
SNAP-25 may lead to increased calcium currents (Condliffe et al.,
2010) and consequently to the onset of epileptic discharges.
CONCLUSIONS AND FUTURE DIRECTIONS
In this review, we have highlighted some of the neurodevelop-
mental pathways that lead to a chronic epileptic condition in
adulthood. Abnormal development of the cerebral cortex (due
to perturbations of neuronal proliferation and/or migration) is
a frequent cause of epilepsy. In addition, more subtle alterations
in the assembly and ﬁne-tuning of neuronal networks may also
lead to an hyperexcitability phenotype later in life. A better under-
standing of the biology of these epileptogenic mechanisms has
important implications for the development of novel therapeutic
approaches.
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